As a peptide supplier with certificate of analysis , we are the go-to Peptide Sciences alternative trusted by the research community
MHRA-approved options for weight management in the UK include semaglutide 2.4 mg (Wegovy), tirzepatide (Mounjaro), orlistat, and naltrexone/bupropion (Mysimba), with eligibility criteria varying by treatment
Nonetheless, possible effects of label leaching over time must be considered [28, 29]
Pricing varies based on medication type, dosing frequency, program length, labs, and support needs
What's the difference between tirzepatide and semaglutide for weight loss